Clinical Trial Update: Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base [Phase 3]

View source ↗

Summary

A Phase 3 bronchoprovocation study is investigating the pharmacodynamics of an albuterol sulfate inhalation aerosol at 90 mcg base in individuals with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Albuterol Sulfate Inhalation Aerosol (eq 90 mcg Base) (albuterol sulfate)

Snippet

Sponsor: Amneal Ireland Limited | Conditions: Asthma | Phase 3 | Status: UNKNOWN